These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11888653)

  • 1. Experimental therapy of filovirus infections.
    Bray M; Paragas J
    Antiviral Res; 2002 Apr; 54(1):1-17. PubMed ID: 11888653
    [No Abstract]   [Full Text] [Related]  

  • 2. [Filoviruses].
    Takada A
    Uirusu; 2012; 62(2):197-208. PubMed ID: 24153230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Filovirus infection: pathogenesis and host specificity].
    Takada A
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1242-7. PubMed ID: 17824247
    [No Abstract]   [Full Text] [Related]  

  • 4. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle.
    Martin B; Canard B; Decroly E
    Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filovirus proteins for antiviral drug discovery: A structure/function analysis of surface glycoproteins and virus entry.
    Martin B; Hoenen T; Canard B; Decroly E
    Antiviral Res; 2016 Nov; 135():1-14. PubMed ID: 27640102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symposium on Marburg and Ebola viruses.
    Klenk HD; Feldmann H
    Virus Res; 2001 Nov; 80(1-2):117-23. PubMed ID: 11597757
    [No Abstract]   [Full Text] [Related]  

  • 7. Reverse genetics systems as tools for the development of novel therapies against filoviruses.
    Hoenen T; Feldmann H
    Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1253-63. PubMed ID: 25169588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Filovirus infection and host factors].
    Takada A
    Tanpakushitsu Kakusan Koso; 2009 Jun; 54(8 Suppl):913-9. PubMed ID: 21089517
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral activity of a small-molecule inhibitor of filovirus infection.
    Warren TK; Warfield KL; Wells J; Enterlein S; Smith M; Ruthel G; Yunus AS; Kinch MS; Goldblatt M; Aman MJ; Bavari S
    Antimicrob Agents Chemother; 2010 May; 54(5):2152-9. PubMed ID: 20211898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Innate immunity evasion mechanisms of filoviruses].
    Martin B; Decroly É
    Med Sci (Paris); 2018; 34(8-9):671-677. PubMed ID: 30230452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral drugs: Spanner in the works of filovirus infection.
    Bray N
    Nat Rev Drug Discov; 2014 May; 13(5):334. PubMed ID: 24722463
    [No Abstract]   [Full Text] [Related]  

  • 12. Filovirus entry into cells - new insights.
    Miller EH; Chandran K
    Curr Opin Virol; 2012 Apr; 2(2):206-14. PubMed ID: 22445965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible leap ahead in filovirus therapeutics.
    Falzarano D; Feldmann H
    Cell Res; 2014 Jun; 24(6):647-8. PubMed ID: 24732011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filovirus proteins for antiviral drug discovery: Structure/function of proteins involved in assembly and budding.
    Martin B; Reynard O; Volchkov V; Decroly E
    Antiviral Res; 2018 Feb; 150():183-192. PubMed ID: 29305306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fighting filoviruses.
    Becker S
    Expert Rev Vaccines; 2007 Feb; 6(1):1-3. PubMed ID: 17280470
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid molecular strategy for filovirus detection and characterization.
    Zhai J; Palacios G; Towner JS; Jabado O; Kapoor V; Venter M; Grolla A; Briese T; Paweska J; Swanepoel R; Feldmann H; Nichol ST; Lipkin WI
    J Clin Microbiol; 2007 Jan; 45(1):224-6. PubMed ID: 17079496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the Type I interferon response in the resistance of mice to filovirus infection.
    Bray M
    J Gen Virol; 2001 Jun; 82(Pt 6):1365-1373. PubMed ID: 11369881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Animal Models for Evaluating Filovirus Countermeasures.
    Banadyga L; Wong G; Qiu X
    ACS Infect Dis; 2018 May; 4(5):673-685. PubMed ID: 29457711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of reverse genetics systems in determining filovirus pathogenicity.
    Theriault S; Groseth A; Artsob H; Feldmann H
    Arch Virol Suppl; 2005; (19):157-77. PubMed ID: 16355872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.
    Shurtleff AC; Nguyen TL; Kingery DA; Bavari S
    Expert Opin Drug Discov; 2012 Oct; 7(10):935-54. PubMed ID: 22873527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.